Form 4: Molina Healthcare CFO Increases Stake with Stock Grant

Molina Healthcare's CFO, Mark Lowell Keim, increased his beneficial ownership by 26,073 shares through a restricted stock grant, despite a tax-related disposition.

Summary

• Mark Lowell Keim, Chief Financial Officer of Molina Healthcare, Inc. (MOH), reported changes in his beneficial ownership of common stock.
• On March 1, 2026, Keim disposed of 2,308 shares of common stock at a price of $154.05 per share to cover withholding taxes related to the vesting of 6,563 shares.
• Concurrently, on March 1, 2026, Keim acquired 26,073 shares of common stock through a restricted stock grant under the Issuer's 2025 Equity Incentive Plan, at a volume-weighted average price of $145.75.
• Following these transactions, Keim's direct beneficial ownership of common stock increased to 83,251 shares.
• The newly granted 26,073 shares will vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
• Additional shares are scheduled to vest: 4,613 shares on March 1, 2027, and 2,892 shares on March 1, 2028.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting ongoing executive compensation and an increase in the CFO's overall beneficial ownership, which aligns management interests with shareholders. It is a routine transaction, not indicative of extraordinary news.

Positives

• The Chief Financial Officer received a significant grant of 26,073 restricted shares, indicating continued alignment of management's interests with shareholders through equity compensation.
• The increase in beneficial ownership to 83,251 shares demonstrates management's ongoing stake in the company's performance.

Negatives

• A disposition of 2,308 shares occurred to cover tax obligations, which is a standard practice for equity vesting but reduces direct ownership in the short term.

Future Outlook

The vesting schedule for the newly granted restricted stock extends through March 1, 2029, indicating a long-term commitment of the Chief Financial Officer to the company's future performance and aligning his incentives with long-term shareholder value creation.

Industry Context

StockSavvy.ai notes that restricted stock grants and subsequent tax-related dispositions are standard components of executive compensation packages in the healthcare industry and across publicly traded companies. This transaction reflects a routine compensation event rather than a discretionary open-market purchase or sale, aligning with common practices for retaining and incentivizing key management personnel.

Stakeholder Impact

• Shareholders: The grant of restricted stock to the CFO aligns management's long-term interests with shareholder value creation, as the value of his compensation is tied to the company's stock performance.
• Employees: The equity incentive plan demonstrates the company's commitment to using stock-based compensation to attract and retain key talent.

Next Steps

• Vesting of 8,709 shares (one-third of 26,073 plus 4,613 additional shares) on March 1, 2027.
• Vesting of 11,597 shares (one-third of 26,073 plus 2,892 additional shares) on March 1, 2028.
• Vesting of 8,691 shares (one-third of 26,073) on March 1, 2029.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving a restricted stock grant and a tax-related disposition. While the CFO's overall beneficial ownership increased, such compensation events are standard and generally do not provide sufficient new information to warrant a change in investment recommendation. Investors should consider broader financial reports and market conditions for a comprehensive assessment.

Keywords

Molina Healthcare, MOH, Form 4, Insider Transaction, Restricted Stock Grant, Equity Incentive Plan, CFO, Beneficial Ownership, Stock Compensation